Vasogen Shares Jump Following Positive Announcement On Celacade
Shares of Vasogen (VSGN) jumped almost 15% after the company announced that its drug Celacade significanly reduced hospital stay relating to heart failure by more than 30%. The company has initiated preparations for an FDA meeting regarding future U.S. Regulatory submission.
Shares of Vasogen (VSGN) jumped almost 15% after the company announced that its drug Celacade significanly reduced hospital stay relating to heart failure by more than 30%. The company has initiated preparations for an FDA meeting regarding future U.S. Regulatory submission.
posted by Nico at
7:44 PM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home